Expression and roles of fatty acid synthase in hepatocellular carcinoma.

@article{Hao2014ExpressionAR,
  title={Expression and roles of fatty acid synthase in hepatocellular carcinoma.},
  author={Qiwei Hao and Tao Li and Xiong Zhang and Ping Gao and Peiyu Qiao and Sheng Li and Zhimin Geng},
  journal={Oncology reports},
  year={2014},
  volume={32 6},
  pages={
          2471-6
        }
}
Cell metabolism abnormalities are closely related to tumor occurrence and development. Fatty acid synthase (FASN) is the key molecule for catalyzing fatty acid synthesis. Increasing evidence indicates that FASN is highly expressed in a number of malignant tumors; it can promote the synthesis of endogenous fatty acids in tumor cells and then the synthesized fatty acids provide energy for the proliferation of tumor cells. However, there has been no systematic study focusing on FASN expression and… 

Figures from this paper

Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma
TLDR
It is found that overexpression of FASN in the mouse liver is unable to malignantly transform hepatocytes, and tumors might be either addicted to or independent from de novo lipogenesis for their growth depending on the oncogenes involved.
Overexpression of the androgen receptor in human hepatoma cells and its effect on fatty acid metabolism.
TLDR
Upregulation of AR via overexpression led to the disturbance of fatty acid metabolism-associated gene expression in human HCC cells, suggesting that the AR may serve a role in hepatocarcinogenesis via the regulation of hepatocellular fatty acids metabolism.
Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression
TLDR
Findings provide new insights into the mechanisms associated with FASn knockdown in CCA cell lines and suggest that targeting FASN may serve as a novel CCA therapeutic strategy.
Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans.
USP14 Regulates Cancer Cell Growth in a Fatty Acid Synthase-Independent Manner
TLDR
It is demonstrated that USP 14 regulates proliferation of the cancer cells in a fatty acid synthase-independent manner, and targeting USP14 in combination with FASN may not be a viable method for effective cancer treatment.
Destabilization of Fatty Acid Synthase by Acetylation Inhibits De Novo Lipogenesis and Tumor Cell Growth.
TLDR
A previously unknown mechanism of FASN regulation involving its acetylation by KAT8 and its deacetylationBy HDAC3 is reported and opportunities to target FASn acetylations as an anticancer strategy are suggested.
Inhibition of FASN suppresses migration, invasion and growth in hepatoma carcinoma cells by deregulating the HIF-1α/IGFBP1 pathway.
TLDR
In the present study, the previous results that FASN was expressed higher in cancer samples than in non-cancerous samples, and influenced migration, invasion and healing of hepatoma carcinoma cells, were verified by immunohistochemistry, tissue microarrays, Transwell assay and wound healing assay.
Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma
TLDR
The mechanisms by which lipid metabolism is involved in hepatocarcinogenesis and tumour adaptation to different conditions are elucidated, focusing on the transcriptional aberrations with new insights in lipidomics and lipid zonation to help detect new putative therapeutic approaches in the second most frequent cause of cancer-related death.
The Role of Lipids in Hepatocellular Carcinoma
TLDR
This chapter focuses on metabolic reprogramming and dysregulation of lipid metabolism as hallmarks of hepatocellular carcinoma.
...
...

References

SHOWING 1-10 OF 21 REFERENCES
Fatty acid synthase expression and esophageal cancer
TLDR
The functional importance of FASN in esophageal tumorigenesis is demonstrated, and it is suggested that inhibiting FASn might be applied to treat esphageal cancer.
Inhibition of fatty acid synthase supresses osteosarcoma cell invasion and migration.
TLDR
The findings suggested that FASN may be involved in osteosarcoma metastasis, as the expression level in the cases with pulmonary metastases was significantly higher than in those without metastasis.
Anti-cancer drugs targeting fatty acid synthase (FAS).
TLDR
Some of the potent FAS inhibitors along with their patent information, the mechanism of anti-cancer effects and the development of more specific and potent F AS inhibitors with lower side effects that are expected to emerge as anti- cancer treatment in the near future are discussed.
Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer
TLDR
Findings indicate that increased FAS expression is one of the earliest and most common events in the development of prostate cancer, suggesting that FAS may be used as a general prostate cancer marker and that antineoplastic therapy based on FAS inhibition may be an option for chemoprevention or curative treatment for nearly all prostate cancers.
Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.
TLDR
De novo lipogenesis has pathogenic and prognostic significance for HCC and inhibitors of lipogenic signaling, including those that inhibit the AKT pathway, might be useful as therapeutics for patients with liver cancer.
Deregulation of lipid metabolism pathway genes in nasopharyngeal carcinoma cells
TLDR
Gene Ontology analysis of the data set revealed that EBERs upregulate the cellular lipid metabolic process and a polyphenolic flavonoid compound, quercetin, known to inhibit FASN, was found to inhibit proliferation of NPC cells.
Increased fatty acid synthase expression and activity during progression of prostate cancer in the TRAMP model
TLDR
The role of FAS up‐regulation during prostate tumor progression in the transgenic adenocarcinoma of mouse prostate (TRAMP) model was investigated and sensitivity to FAS anti‐metabolites was analyzed to determine therapeutic potential of Fas inhibition in the treatment of prostate cancer.
...
...